Prenosis
Prenosis, based in Chicago, IL, is at the forefront of precision medicine in acute care, utilizing its Immunix™ platform to develop innovative diagnostic tools that enhance patient care. The Sepsis ImmunoScore™, the first FDA authorized AI diagnostic for sepsis, integrates biomarkers and clinical data to provide real-time insights and predictive outcomes for effective patient treatment.
The company's mission is to empower healthcare providers by delivering a comprehensive understanding of each patient's biology, enabling tailored therapies that improve outcomes and drive down costs. With an expanding network of hospitals and a robust biobank, Prenosis is committed to reshaping the landscape of acute care through personalized medicine.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.